Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

13.22
+0.87007.04%
Post-market: 13.220.00000.00%18:43 EDT
Volume:1.55M
Turnover:20.95M
Market Cap:721.77M
PE:15.08
High:14.50
Open:12.93
Low:12.54
Close:12.35
Loading ...
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Correspondence

Form CORRESP - Correspondence
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]